Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: A single center experience

Mutations in the tumor suppressor gene TP53 are detected in 5–10% of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes. TP53 mutations have been associated with complex karyotypes, therapy-related malignancies, lower response rates to cytotoxic chemotherapy, and an overall adv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Bewersdorf, Jan Philipp, Shallis, Rory M., Gowda, Lohith, Wei, Wei, Hager, Karl, Isufi, Iris, Kim, Tae Kon, Pillai, Manoj M., Seropian, Stuart, Podoltsev, Nikolai A., Gore, Steven D., Siddon, Alexa J., Zeidan, Amer M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7603787/
https://ncbi.nlm.nih.gov/pubmed/32362171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2020.1759051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados